StockClub

BRTX

BRTXBioRestorative Therapies, Inc.$ --
BioRestorative Therapies, Inc.

BioRestorative Therapies, Inc.

BRTX

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
0M USD
YoY -7.3%
Operating Income
-3M USD
YoY +29.6%
Net Income
-2M USD
YoY +59.7%
EPS
-0.24$
YoY +62.5%

Revenue

$23,170
FY2024 Q2$124,100
$124,100
Q2
FY2024 Q3$357,700
$357,700
Q3
FY2024 Q4$401,000
$401,000
Q4
FY2025 Q1$25,000
$25,000
Q1
FY2025 Q2$328,300
$328,300
Q2
FY2025 Q3$340,100
$340,100
Q3
FY2025 Q4$359,700
$359,700
Q4
FY2026 Q1$23,170
$23,170
Q1
Actual
$-1,830 (-7.3%)

Net Income

$-2.2M
FY2024 Q2$-6.3M
$-6.3M
Q2
FY2024 Q3$-7.3M
$-7.3M
Q3
FY2024 Q4$-9M
$-9M
Q4
FY2025 Q1$-5.3M
$-5.3M
Q1
FY2025 Q2$-8M
$-8M
Q2
FY2025 Q3$-11M
$-11M
Q3
FY2025 Q4$-14.2M
$-14.2M
Q4
FY2026 Q1$-2.2M
$-2.2M
Q1
Actual
+$3.2M (+59.7%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$77,000
FY2020
$77,000
FY2021
Actual:$46,000
FY2021
$46,000
FY2022BEAT
Actual:$119,800
Est:$100,000
FY2022BEAT
$119,800
FY2023MISS
Actual:$145,800
Est:$149,500
FY2023MISS
$145,800
FY2024MISS
Actual:$401,000
Est:$855,333
FY2024MISS
$401,000
FY2025MISS
Actual:$359,700
Est:$490,000
FY2025MISS
$359,700

Analyst Estimates